A Pilot Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Small Cell Lung Carcinoma (SCLC)
Latest Information Update: 12 Jul 2018
At a glance
- Drugs Devimistat (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 07 Jun 2016 This study has been closed early due to lack of efficacy, as per an abstract presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 07 Jun 2016 Status changed from active, no longer recruiting to discontinued, as per an abstract presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology